Clinical Trial Update: Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Golcadomide (CELMoD) with rituximab, with or without nivolumab, for newly diagnosed follicular lymphoma; trial status is activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Golcadomide (golcadomide)
• Rituximab (rituximab)
• nivolumab (nivolumab)

Snippet

Sponsor: Olivia Newton-John Cancer Research Institute | Conditions: Follicular Lymphoma Stage II, Follicular Lymphoma Stage III | Phase 2 | Status: ACTIVE_NOT_RECRUITING